Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Study on tPA-mediated MMP Regulation in Rat Neuronal Cells.

뇌신경세포에서 tPA에 의한 MMP의 발현 조절에 관한 연구

  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Tissue plasminogen activator (tPA) is very useful for dissolving the clots of blood, however, the use of tPA is limited to only 3-5% of ischemic stroke patients because of the narrow therapeutic time windows and negative side effects. Previous evidences suggest that limitation of tPA in thrombolytic therapy may be related to the upregulation of MMPs. However, little is known about the regulatory mechanism. In this study, we examined the role of tPA on MMP upregulation in rat neuronal cells. tPA (5 ${\mu}g$/ml) increased MMP-9 levels of neuronal cells in a time dependent manner. Hypoxia/reoxygenation amplified tPA-induced MMP-9 levels significantly. Pretreatment with JNK inhibitor SP600125 reduced the MMP-9 response. These results suggest that tPA can upregulate MMPs in neuronal cells and that JNK kinase may be involved.

뇌졸중 치료에 사용되는 tPA는 탁월한 혈전 용해 효과를 보이고 있어 혈액의 흐름을 용이하게 하는데 중요한 역할을 한다. 그러나 tPA 치료법은 매우 짧은 시간 내에 사용해야하는 단점과 출혈, 부종과 같은 여러 가지 부작용이 수반될 수 있기 때문에 매우 제한적이다. 이전의 실험 결과에 따르면 tPA의 이러한 양면적인 현상은 MMP의 활성 조절과 관련이 있는 것으로 보고되어 있으나 세포시스템을 활용한 이들의 직접적인 효과나 조절 기전에 대한 연구는 거의 알려져 있지 않다. 본 연구는 임상에서 사용되는 tPA의 부정적인 효과를 극복하기 위한 방안을 모색하고자 tPA와 MMP 활성과의 조절 기전을 살펴보았다. 랫트의 뇌로부터 추출한 신경세포에서 tPA의 처리는 MMP의 발현을 촉진시켰고 저산소상태에서 tPA에 의한 MMP활성 증가가 더욱 가속화되었으며 JNK 신호전달 경로를 통해 조절되는 것을 확인하였다.

Keywords

References

  1. del Zoppo, G. J. and T. Mabuchi. 2003. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 23, 879-894
  2. Guo, S. and E. H. Lo. 2008. Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 40 (3suppl), s4-7
  3. Hacke, W., T. Brott, L. Caplan, D. Meier, C. Fieschi, R. von Kummer, G. Donnan, W. D. Heiss, N. G. Wahlgren, M. Spranger, G. Boysen, and J. R. Marler. 1999. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53, S3-S14 https://doi.org/10.1212/WNL.53.1.3
  4. Heidinger, M., H. Kolb, H. W. Krell, M. Jochum, and C. Ries. 2006. Modulation of qutocrine TNF-alpha stimulated matrix metalloproteinase-9 expression by mitogen activated protein kinases in THP-1 monocytic cells. J. Biol. Chem. 387,69-78 https://doi.org/10.1515/BC.2006.010
  5. Kim, K. C. and C. H. Lee. 2005. MAP kinase activation is required for the MMP-9 induction by TNF-stimulation. Arch Pharmacol. Res. 28, 1257-1262 https://doi.org/10.1007/BF02978209
  6. Lapchack, P. A., D. M. Arujo, S. Pakola, D. Song, J. Wei, and J. A. Zivin. 2002. microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 33, 2279-2284 https://doi.org/10.1161/01.STR.0000028267.09604.7B
  7. Lee, S. R. and E. H. Lo. 2004. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 24, 720-727 https://doi.org/10.1097/01.WCB.0000122747.72175.47
  8. Lo, E. H., T. Dalkara, and M. A. Moskowitz. 2003. Mechanism, challenges and opportunites in stroke. Nat. Rev. Neurosci. 4, 399-415 https://doi.org/10.1038/nrn1106
  9. Rosell, A., C. Foerch, Y. Murata, and E. H. Lo. 2008. Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir. Suppl. 105, 173-178 https://doi.org/10.1007/978-3-211-09469-3_34
  10. Sumii, T. and E. H. Lo. 2002. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focalischemia in rat. Stroke 33, 831-836 https://doi.org/10.1161/hs0302.104542
  11. Tsuji, K., T. Aoki, E. Tejima, K. Arai, S. R. Lee, D. N. Atochin, P. L. Huang, X. Wang, J. Montaner, and E. H. Lo. 2005. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36, 1954-1959 https://doi.org/10.1161/01.STR.0000177517.01203.eb
  12. Wang, X., A. Rosell, and E. H. Lo. 2008. Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy. CNS Neurol. Disord. Drug Targets 7, 235-242 https://doi.org/10.2174/187152708784936635
  13. Wang, X., K. Tsuji, S. R. Lee, M. M.. Ning, K. L. Furie, A. M. Buchan, and E. H. Lo. 2004. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemia stroke. Stroke 35 (suppl1), 2726-2730 https://doi.org/10.1161/01.STR.0000143219.16695.af
  14. Wardlaw, J. M., P. A. Sandercock, and E. Berge. 2003. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? Acumulative meta-analysis. Stroke 34, 1437-1442 https://doi.org/10.1161/01.STR.0000072513.72262.7E